First Page | Document Content | |
---|---|---|
![]() Date: 2013-11-29 23:25:28Costs Quality-adjusted life year Cost-effectiveness analysis Incremental cost-effectiveness ratio Cancer screening Bevacizumab Cost–benefit analysis Screening ICER Medicine Health Health economics | Add to Reading List |